Assessing respiratory dysfunction and frailty in allergic and eosinophilic asthma patients
Comparison of Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics
This study is trying to see how breathing problems and fatigue affect people with allergic and eosinophilic asthma, to help create better treatment plans for them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 35 Years to 75 Years |
| Sex | All |
| Sponsor | Hacettepe University Academic / other |
| Locations | 1 site (Ankara, State) |
| Trial ID | NCT06796894 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the levels of respiratory dysfunction, symptoms, and frailty in patients diagnosed with allergic and eosinophilic asthma. By analyzing different endophenotypes, the study seeks to identify variations in pulmonary function, dyspnoea, fatigue, and overall quality of life. The findings are expected to inform tailored rehabilitation approaches for asthma management based on the specific characteristics of these patient groups. The study will include participants aged 35-75 years who meet specific diagnostic criteria for asthma.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 35-75 years diagnosed with allergic or eosinophilic asthma.
Not a fit: Patients with cognitive impairment or those who have had an acute asthma attack recently may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective rehabilitation strategies for asthma patients.
How similar studies have performed: While the study focuses on specific endophenotypes of asthma, similar studies have shown promise in understanding asthma phenotypes and tailoring treatments accordingly.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 35-75 years, * Diagnosed with allergic or eosonophilic asthma according to the Global Strategy for the Prevention and Treatment of Asthma (GINA). Exclusion Criteria: * Known cognitive impairment, * Having had an acute asthma attack in the last 6 weeks, * Having changed medication in the last 4 weeks.
Where this trial is running
Ankara, State
- Hacettepe University — Ankara, State, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Ebru Calik Kutukcu — Hacettepe University
- Study coordinator: Ebru Calik Kutukcu, PhD
- Email: ebru.calik@hacettepe.edu.tr
- Phone: 3123051576
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.